Troponin to ID Diabetes Patients With Silent Heart Disease?
Nearly 1 in 5 US adults with type 2 diabetes but without symptoms of cardiovascular disease (CVD) have a clinically meaningful elevation of a marker of cardiac damage — namely, high sensitivity cardiac troponin T (hs-cTnT) — based on data from a representative sample of more than 10,000 US adults.
The finding suggests hs-cTnT maybe a useful marker for adults with diabetes who could benefit from more aggressive CVD risk reduction despite having no clinical indications of CVD.
The results "highlight the substantial burden of subclinical CVD in persons with diabetes and emphasize the importance of early detection and treatment of CVD for this high-risk population," say the authors of the research, published today in the Journal of the American Heart Association.
Vous désirez lire la suite de cet article ?
Inscrivez-vous